PH22534A - Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide - Google Patents

Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide

Info

Publication number
PH22534A
PH22534A PH32282A PH32282A PH22534A PH 22534 A PH22534 A PH 22534A PH 32282 A PH32282 A PH 32282A PH 32282 A PH32282 A PH 32282A PH 22534 A PH22534 A PH 22534A
Authority
PH
Philippines
Prior art keywords
ribofuranosyl
carboxamide
triazole
medical treatment
viral diseases
Prior art date
Application number
PH32282A
Other languages
English (en)
Inventor
Smith Roberts Angus
Fernandez Humberto
Original Assignee
Vira Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH22534(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vira Tek Inc filed Critical Vira Tek Inc
Publication of PH22534A publication Critical patent/PH22534A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PH32282A 1984-10-29 1985-05-16 Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide PH22534A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29

Publications (1)

Publication Number Publication Date
PH22534A true PH22534A (en) 1988-10-17

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32282A PH22534A (en) 1984-10-29 1985-05-16 Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide

Country Status (18)

Country Link
EP (3) EP0383361A3 (fr)
JP (1) JPH0713019B2 (fr)
KR (1) KR860003018A (fr)
AT (1) ATE204173T1 (fr)
AU (1) AU584333B2 (fr)
BE (1) BE902199A (fr)
CA (1) CA1261265A (fr)
DD (1) DD261094A5 (fr)
DE (3) DE3588232T2 (fr)
ES (1) ES8704962A1 (fr)
FR (1) FR2572286B1 (fr)
GB (1) GB2166050B (fr)
LU (1) LU85854A1 (fr)
NL (1) NL300083I1 (fr)
NZ (1) NZ212510A (fr)
PH (1) PH22534A (fr)
PT (1) PT81387B (fr)
ZA (1) ZA858237B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126696T1 (de) * 1985-12-23 1995-09-15 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
PL364699A1 (en) * 1999-01-29 2004-12-13 Icn Pharmaceuticals, Inc. Modulation of immune response by ribavirin
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20170128482A1 (en) 2014-06-23 2017-05-11 Sanovel Ilac Sanayi Ve Ticaret A.S. Modified release pharmaceutical compositions of sofosbuvir and ribavirin
US20170151272A1 (en) 2014-06-23 2017-06-01 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A novel pharmaceutical composition of sofosbuvir and ribavirin
EA201692507A1 (ru) 2014-06-23 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. Фармацевтические комбинации софосбувира и рибавирина
JP2018076280A (ja) * 2016-10-28 2018-05-17 国立大学法人 大分大学 ジカウイルス感染症治療用医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
WO1983003383A1 (fr) * 1982-03-29 1983-10-13 Liposome Co Inc Vesicules plurilamellaires stables

Also Published As

Publication number Publication date
ES548303A0 (es) 1987-04-16
JPH0713019B2 (ja) 1995-02-15
ZA858237B (en) 1988-02-24
DE181050T1 (de) 1986-12-18
CA1261265A (fr) 1989-09-26
HK1010985A1 (en) 1999-07-02
DE10299005I1 (de) 2002-05-08
LU85854A1 (fr) 1985-12-16
NL300083I1 (nl) 2002-05-01
DE3588232D1 (de) 2001-09-20
AU584333B2 (en) 1989-05-25
EP0643970B1 (fr) 2001-08-16
EP0181050A3 (fr) 1987-10-21
PT81387B (pt) 1987-11-11
DE10299005I2 (de) 2004-07-01
PT81387A (en) 1985-11-01
GB2166050A (en) 1986-04-30
FR2572286B1 (fr) 1990-03-23
EP0181050A2 (fr) 1986-05-14
GB8509689D0 (en) 1985-05-22
AU4180785A (en) 1986-05-08
BE902199A (fr) 1985-07-31
JPS61109723A (ja) 1986-05-28
GB2166050B (en) 1989-08-16
EP0643970A3 (fr) 1997-07-09
EP0643970A2 (fr) 1995-03-22
NZ212510A (en) 1989-04-26
DE3588232T2 (de) 2002-06-13
FR2572286A1 (fr) 1986-05-02
EP0383361A3 (fr) 1993-06-16
KR860003018A (ko) 1986-05-19
DD261094A5 (de) 1988-10-19
ATE204173T1 (de) 2001-09-15
ES8704962A1 (es) 1987-04-16
EP0383361A2 (fr) 1990-08-22

Similar Documents

Publication Publication Date Title
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
MY130035A (en) Antiviral compounds
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
PH22534A (en) Method of medical treatment of human viral diseases utilizing 1-b- -d-ribofuranosyl-1,2,4-triazole-3-carboxamide
GB9425730D0 (en) Compounds
MY124071A (en) Treatment of viral disease in swine
NO965556L (no) Trippelkombinasjon mot HIV
EP0757697A4 (fr) Utilisation d'agents bloquant l'interaction molecule d'adhesion intercellulaire/recepteur dans le traitement d'une infection respiratoire virale
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
DK664188D0 (da) Butylhydroxyanisoler til behandling af retrovirale sygdomme
FI834429A7 (fi) 3',5'-diarabinosidien valmistus ja terapeuttinen soveltaminen.
TR199901998T2 (xx) 9,10-sekokolesta-5,7,10(19)-triyen-1,3-diyol veya alfakasidol�n kullan�m�.
UA23352A (uk) beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ
IT8522576A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
JPS5519244A (en) Anti-malignant tumor agent
FR2786099B1 (fr) Nouvelle application therapeutique de la 1,6-dimethyl-8beta- hydroxymethyl-10alpha-methoxyergoline
ATE81587T1 (de) Medizinisches praeparat zur behandlung von hautleiden.
IS3304A7 (is) Aðferð til framleiðslu, notkun og samsetning efnablöndu til meðhöndlunar sóriasis, gigtar eða andarteppusjúkdóma.